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Abstract—Deep pressure ulcers represent a major problem for
individuals with spinal cord injury (SCI), with the initial dam-
age often hidden underneath intact skin. Accordingly, early
detection is difficult and treatment is problematic. In the
present study, circulatory levels of biomarkers for muscle dam-
age were investigated to explore their potential in the early
detection of deep pressure ulcers. Baseline concentrations of
creatine kinase, myoglobin (Mb), heart-type fatty acid binding
protein (H-FABP), and C-reactive protein (CRP) were meas-
ured in small groups of nondisabled (age 39–66 yr) subjects
and subjects with SCI (age 40–68 yr, American Spinal Injury
Association grade A–B, level of injury thoracic 11 to lumbar 3)
over a period of 5 days. Each subject exhibited a unique con-
centration profile for all markers, although some correlations
were observed; for example, Mb and H-FABP were correlated
for both subject groups. No significant differences were found
in marker concentrations between the two subject groups,
although a trend toward higher CRP levels was observed in the
SCI subjects. Furthermore, one SCI subject with a category II
pressure ulcer exhibited higher H-FABP and CRP concentra-
tions than all other subjects. Because the variations in each of
the marker concentrations were smaller than the predicted
increases after pressure ulcers, this combination of plasma
markers may prove appropriate for the early detection of deep
pressure ulcers.
Key words: C-reactive protein, creatine kinase, deep tissue
injury, early detection, heart-type fatty acid binding protein,
muscle damage, myoglobin, plasma concentrations, pressure
ulcers, spinal cord injury.
INTRODUCTION
A pressure ulcer is a local lesion to the skin and/or
underlying tissues resulting from prolonged mechanical
loading involving pressure alone or in combination with
shear and/or friction [1]. Two types of pressure ulcers can
be distinguished. Superficial pressure ulcers involve the
skin layer only, while deep pressure ulcers are often initi-
ated in deep muscle tissue adjacent to bony prominences
[2]. The latter ulcers only become apparent at the skin
surface when tissue destruction is extensive, having pro-
gressed up from the muscle layers. Accordingly, early
detection and prevention is problematic and subsequent
treatment is prolonged, with a variable prognosis.
Abbreviations: ASIA = American Spinal Injury Association,
CK = creatine kinase, CRP = C-reactive protein, ELISA =
enzyme-linked immunosorbent assay, H-FABP = heart-type
fatty acid binding protein, Mb = myoglobin, SCI = spinal cord
injury, SCI-A = SCI active, SCI-NA = SCI nonactive, SCI+PU =
SCI plus pressure ulcer, T = thoracic, U/L = units per liter.
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Subjects with spinal cord injury (SCI) are particularly
susceptible to deep pressure ulcers because of their inher-
ent impaired sensitivity, disuse muscle atrophy, and
impaired vascularity [3–4]. Accordingly, the prevalence of
pressure ulcers in this population has been studied fre-
quently to identify risk factors and determine individual
susceptibility to pressure ulcer development [5–6]. For
example, Rodriguez and Claus-Walker postulated that the
established change in skin resistance to external forces
post-SCI could be attributed to breakdown of the structural
protein collagen [7]. They reported increased levels of the
collagen degradation products hydroxylysine and hydroxy-
proline in a small group of SCI subjects, suggesting
decreased skin stiffness and strength. Other research for
identifying persons at risk for pressure ulcers examined the
metabolites of sweat collected at the skin surface. In com-
pressed skin, the impairment of both blood supply and
lymphatic drainage could lead to increased production of
urea, lactate, and urate [8–9]. However, the simple method
of sweat collection requires a significant sweat volume for
analysis and thus may not prove appropriate for SCI sub-
jects with altered or reduced sudomotor function.
In the present study, circulatory levels of biomarkers
for muscle damage were investigated to explore the pos-
sibility of using them for detection of deep pressure
ulcers. Three markers of muscle damage and one marker
of inflammation were chosen for investigation:
    • Creatine kinase (CK), an enzyme with a combined
molecular mass of 86 kDa involved in cellular ener-
getics and muscle metabolism, which is mostly found
in skeletal and cardiac muscle and the brain [10].
  • Myoglobin (Mb), a cytoplasmic hemoprotein of 18 kDa,
which is present in skeletal and cardiac muscle [10].
    • Heart-type fatty acid binding protein (H-FABP), a
protein of 15 kDa involved in the cellular uptake,
transport, and metabolism of fatty acids in skeletal
and cardiac muscle and the kidneys [10].
    • C-reactive protein (CRP), a ubiquitous marker in
inflammation, tissue damage, and infection [11]. CRP
levels are generally higher in SCI subjects compared
with nondisabled controls because of their chronic
inflammatory state [12].
The concentrations of these proteins in the circula-
tion are determined by their release from the injured tis-
sue and the clearance by the kidneys [13]. In a study with
nondisabled human volunteers, levels of CK, Mb, and H-
FABP all increased after eccentric exercise [14]. The
time to reach peak concentration and subsequently return
to baseline levels was shorter for Mb and H-FABP than
CK, which can be explained by the differences in molecu-
lar mass of these proteins. These markers have also been
used to detect cardiac muscle damage. Skeletal muscle
damage can be distinguished from cardiac muscle dam-
age by calculating the ratio of the Mb concentration over
the H-FABP concentration, which is considerably higher
in the case of skeletal muscle damage (with ratios of 20–
70) when compared with cardiac muscle damage (with
ratios of ~5) [15]. With respect to pressure ulcers, several
studies have reported considerable increases in CK levels
in serum and wound exudate in animal studies on deep
pressure ulcers [16–18]. Furthermore, higher serum lev-
els of CRP were observed in SCI subjects with pressure
ulcers than in subjects without ulcers [12,19–20].
This study represents a preliminary investigation of
the basal circulatory levels and variations of these four
markers in nondisabled subjects and SCI subjects with a
low-level lesion (injury level thoracic [T] 11 or lower), in
which one SCI subject had a pressure ulcer. To assess
whether these markers are appropriate for early detection,
we asked the following questions:
1. What are the baseline circulatory levels of these mark-
ers in SCI subjects and is there a difference compared
with nondisabled individuals?
2. How large are the variations of the markers within a
day and during a week?
3. Are the variations smaller than variations expected
when a pressure ulcer develops or exists?
4. Are there any relationships between the circulatory
levels of these markers?
METHODS
Participants
The participants in this study included eight male sub-
jects with traumatic SCI (mean age 56, range 40–68) who
were former patients of a rehabilitation center (Adelante;
Hoensbroek, the Netherlands). The participant information
is detailed in Table 1. One subject, 11 yr postinjury, pre-
sented with a category II pressure ulcer at the sacrum
(ulcer had been present for a year) and had American Spi-
nal Injury Association (ASIA) Impairment Scale classifi-
cation A [21], with neurologic level of injury T12 (SCI
plus pressure ulcer [SCI+PU] group, n = 1). This subject
also suffered from diabetes, hypertension, high cholesterol,
and had a stoma. Of the remaining participants (SCI group,363
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n = 7), who were between 1 and 33 yr postinjury, six had
an ASIA-A classification and one had an ASIA-B classifi-
cation [21]. The neurological level of injury in these seven
subjects was between T11 and lumbar 3. One of these sub-
jects had diabetes and high cholesterol and two had hyper-
tension. To investigate the effect of exercise on the marker
levels, we divided the SCI group into two subgroups, SCI
active (SCI-A) and SCI nonactive (SCI-NA), based on the
individual motor function of the subjects. SCI-A subjects
regularly walked with crutches or a parapodium during the
week, while SCI-NA subjects did not. For comparison, a
control group of age-matched male subjects was recruited
from volunteers at the Eindhoven University of Technol-
ogy, consisting of seven nondisabled participants without
any known comorbidities (control group, n = 7; Table 1).
Experimental Protocol
Blood was drawn by a standard venipuncture from all
subjects on 5 consecutive days. One blood sample per day
was taken in the early afternoon after lunch for 4 days. On
the fifth day, three samples were taken: in the morning
(after breakfast), early afternoon, and late afternoon. Blood
samples were collected in two 5 mL Vacutainer collection
tubes (BD; Franklin Lakes, New Jersey), which contained
Olefin gel, heparin, and lithium to prevent coagulation.
Blood was centrifuged at 3,000 rpm for 10 min. Plasma
was transferred into two vials, one of which was analyzed
for CK, Mb, and CRP content. The vial used for H-FABP
analysis was stored at 80 °C and subsequently tested with
an enzyme-linked immunosorbent assay (ELISA). Basic
clinical and demographic information was obtained
through a questionnaire. Furthermore, all participants filled
in a diary to monitor their level of exercise related to work,
sports, or any special circumstances.
Biochemical Analysis
The CK, Mb, and CRP contents were determined using
a photometer (Analyzer Roche type Modular; Roche, Swit-
zerland). CK catalyzes the reaction of phosphocreatine with
adenosine diphosphate to creatine and adenosine triphos-
phate. The content of the reduced form of nicotinamide
adenine dinucleotide phosphate, which is directly propor-
tional to the CK content, was measured photometrically.
The detection range was 3 to 2,300 units per liter (U/L).
The CRP content was also determined by photometry, with
a detection range of 1 to 350 mg/L. Electrochemilumines-
cence, a sandwich-principle–based immunoassay, was used
for Mb detection in plasma samples, with a detection range
of 21 to 3,000 g/L. The coefficients of variation for total
precision of the CK, CRP, and Mb concentrations were
<1.4, <6.2, and <5.2 percent, respectively. H-FABP ELI-
SAs (Hycult Biotech; Uden, the Netherlands) were used to
detect the concentration of H-FABP in all samples. This
assay is a solid-phase ELISA based on the sandwich princi-
ple. Samples and standard were tested in duplicate and
averaged. The detection range of the ELISA was 0.1 to
25.0 ng/mL.
Statistical Analysis
To compare the marker concentrations of the nondis-
abled and SCI subjects, the median marker concentrations
over the 5 days were calculated for each individual. Sub-
sequently, the presence of significant differences in
median marker levels between the groups was determined
Table 1.
Characteristics of study participants.
Characteristic
Control
(n = 7)
SCI
(n = 7)
SCI+PU
(n = 1)
Age (years)
    Median 55 56 59
    Range 39–66 40–68 —
BMI (kg/m2)
    Median 24 25 31
    Range 21–29 22–28 —
ASIA Grade
    A — 6 1
    B — 1 —
Injury Level
    T11 — 2 —
    T12 — — 1
    L1 — 1 —
    L2 — 2 —
    L3 — 2 —
Years Postinjury
    Median — 15 11
    Range — 1–33 —
Previous Pressure Ulcers
    Median — 1 3
    Range — 0–3 —
Comorbidities
    Diabetes — 1 1
    Hypertension — 2 1
    High Cholesterol — 1 1
ASIA = American Spinal Injury Association, BMI = body mass index, L = lum-
bar, SCI = spinal cord injury, SCI+PU = SCI plus pressure ulcer, T = thoracic.364
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using the nonparametric Wilcoxon rank sum test. The
presence of diurnal variations in marker levels was inves-
tigated by applying the nonparametric Friedman test to
the marker concentrations that were measured in the
morning and the early and late afternoon of the same day,
followed by a Bonferroni post hoc test. Correlations
between the marker levels were assessed using the Spear-
man rank correlation coefficient. Test results were consid-
ered significant if p < 0.05.
RESULTS
Intersubject Variations
The marker concentrations of the four proteins on the
5 consecutive days are shown in Figure 1. These concen-
trations indicate that the majority of intrasubject variations
were small compared with the intersubject variations in
marker levels, even within groups. For CK in the control
group, the largest values for both concentration and varia-
tion were observed in subject 3 (185–599 U/L). In the SCI
group without pressure ulcers, the greatest concentrations
were present in subject 7 (306–467 U/L). The SCI+PU sub-
ject showed relatively low CK levels with a small variation
(30–70 U/L). For Mb, only minor intersubject variations
were observed for the control group, with median concen-
trations ranging from 43 to 67 ng/mL. The greatest Mb
concentrations were found in subject 4 (128–171 ng/mL)
of the SCI group. The Mb levels of the SCI+PU subject
were comparable with both other subject groups. For H-
FABP, the intersubject variations were also greater than
the intrasubject variations, although the differences in the
former were smaller than for CK. SCI subject 7 (1.6–7.1
ng/mL) showed the largest variation in H-FABP levels,
and the highest concentrations were observed for the
SCI+PU subject (6.7–9.3 ng/mL). The largest variations
in CRP levels were found in control subject 6 (2–7 g/mL),
and SCI subjects 3 (8–14 g/mL), 4 (12–22 g/mL), and 5
(4–14 g/mL). The highest CRP concentrations were
present in the SCI+PU subject (24–29 g/mL).
Diurnal Variations
Figure 2 shows the marker concentrations of the
samples that were taken in the morning and the early and
late afternoon of the same day. Close examination of the
diurnal data using the Friedman test indicated some
significant differences between time points in the group
of SCI subjects. In particular, the concentrations of Mb in
the morning were greater than those measured in the late
afternoon (p = 0.03). For H-FABP, the morning concen-
trations were greater than those in the early afternoon
(p = 0.02). For the other markers, no significant differ-
ences in concentration were present between the different
time points in both the control and SCI groups.
Comparison of Groups
The group data of the marker concentrations on the
5 consecutive days are summarized in Table 2. For the
group comparisons, the SCI group was presented both as a
single group and divided into two groups according to indi-
vidual motor function; SCI active (SCI-A, subjects 1–3, 7)
and SCI nonactive (SCI-NA, subjects 4–6). The group data
are also displayed in Figure 3. The Wilcoxon rank sum test
revealed no significant differences between the groups of
nondisabled and SCI subjects for any of the markers. Also,
no significant differences were found between the SCI-A
and SCI-NA groups.
The SCI+PU subject showed relatively low CK con-
centrations compared with the other groups (Figure 3(a)).
Furthermore, the CK concentrations in the SCI-A subjects
were larger than the concentrations in the SCI-NA group,
although this result could not be confirmed by statistical
analysis (p = 0.06). The median Mb concentrations were
comparable in all groups (Figure 3(b)). For H-FABP, simi-
lar concentrations were present in nondisabled and SCI
subject groups (Figure 3(c)). The median ratio of Mb
over H-FABP showed values within the range for skeletal
muscle damage (20–70 [15]) for the control group and the
SCI groups without pressure ulcers (Table 2). The
SCI+PU subject exhibited relatively high H-FABP con-
centrations, with a correspondingly reduced value of the
Mb/H-FABP ratio. However, similar values of this ratio
were also observed for some individuals within the SCI
group. In general, the CRP levels were higher in the SCI
subjects than in the control group, although this result
could not be confirmed by statistical analysis (p = 0.14).
Furthermore, we observed a trend toward higher CRP
concentrations in the SCI-NA subjects compared with the
SCI-A subjects (p = 0.23) (Figure 3(d)).
Correlations Between Marker Concentrations
The Spearman rank correlation coefficient revealed
significant correlations in four pairs of markers in the SCI
group and three in the group of nondisabled volunteers
(Table 3). Positive correlations between CK and H-FABP
and Mb and H-FABP were present in both groups. In365
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Figure 1.
Concentrations of (a) creatine kinase (CK), (b) myoglobin (Mb), (c) heart-type fatty acid binding protein (H-FABP), and (d) C-reactive
protein (CRP) for all subjects in samples taken on 5 consecutive days. SCI = spinal cord injury, SCI+PU = SCI plus pressure ulcer,
U/L = units per liter.366
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Figure 2.
Concentrations of (a) creatine kinase (CK), (b) myoglobin (Mb), (c) heart-type fatty acid binding protein (H-FABP), and (d) C-reactive
protein (CRP) for all subjects in 3 samples taken in morning, and early (1) and late (2) afternoon of same day. *Significant difference
between time points. SCI = spinal cord injury, U/L = units per liter.367
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addition, there was a positive correlation between CK and
Mb in the control group. By contrast, there were negative
correlations between CK and CRP and between H-FABP
and CRP in the SCI group.
DISCUSSION
The present study was conducted to investigate the
basal circulatory levels and variations of three markers of
muscle damage and one marker of inflammation in con-
trol and SCI subjects with lesions in the lower T or lumbar
spines. No significant differences were found between the
groups of nondisabled and SCI subjects for any markers.
The CRP levels in the SCI subjects were generally higher
than in the nondisabled controls, although this result
could not be confirmed by statistical analysis (p = 0.14).
The one SCI+PU subject revealed relatively high H-
FABP and CRP values compared with all other subjects.
In addition, close examination of the SCI group revealed
trends toward higher CK (p = 0.06) and lower CRP (p =
0.23) baseline values in those SCI subjects with motor
function (SCI-A) compared with those lacking motor
function (SCI-NA).
The results of this study reveal a small intrasubject
range for all markers when compared with the intersubject
differences. Each subject has a different range of marker
values, which could, in part, be explained by their different
levels of activity as reported in the individual diaries. The
present findings reveal significant diurnal variations within
the SCI subjects for Mb and H-FABP, with morning values
generally elevated compared with those collected later in
the day, a trend previously reported with nondisabled sub-
jects [22–23]. Although daily activities might have been
predicted to increase marker values, the observed decrease
may be a direct result of an increased glomerular filtration
rate during the day [23].
The SCI group demonstrated relatively high CRP lev-
els compared with the control group, supporting findings
from recent studies [12,24]. CRP plasma levels are
affected in multiple situations, increasing rapidly after
both tissue damage and many forms of inflammation and
infection. This marker has often been used with SCI sub-
jects, and its increase has also been reported in individuals
with pressure ulcers [12,19–20]. However, other proin-
flammatory cytokines, such as interleukin-2 receptor and
interleukin-6, may also be appropriate, as has recently
been reported in studies with SCI subjects [25–26].
Close examination of the SCI group revealed trends
toward higher baseline concentrations of CK for the SCI-A
subjects compared with both the SCI-NA and control
groups. The SCI-A group regularly walked with crutches
or a parapodium during the week, which represents inten-
sive and strenuous exercise for the muscles, thereby releas-
ing relatively large amounts of CK into the circulation.
This result matches the findings that nondisabled subjects
who regularly exercise tend to have higher circulatory lev-
els of CK than their sedentary counterparts [27–28]. In
addition, relatively low CRP levels were present in the
SCI-A group compared with the SCI-NA group, which is
consistent with the findings of a recent study in which
decreasing levels of CRP were reported with increasing
levels of activity in a chronic SCI group [20].
Correlational analyses yielded positive relationships
that were statistically significant between CK and H-FABP
and Mb and H-FABP for both SCI and control groups, and
a positive correlation between CK and Mb was also found
in the control group (Table 3). These findings imply a
Table 2.
Concentrations of markers of muscle damage (CK, Mb, and H-FABP),
and inflammation (CRP) in control, SCI, and SCI+PU groups on
5 consecutive days. SCI group was presented both as single group
and divided into two groups according to individual motor function;
SCI active (SCI-A, subjects 1–3, 7) and SCI nonactive (SCI-NA,
subjects 4–6).
Group
CK
(U/L)
Mb
(ng/mL)
H-FABP
(ng/mL)
Ratio
(Mb/H-
FABP)
CRP
(µg/mL)
Control (n = 7)
    Median 102 54 1.3 39 1
    Range 64–599 34–105 0.3–5.1 15–126 1–7
SCI (n = 7)
    Median 144 50 1.7 29 4
    Range 38–467 8–171 0.2–7.1 6–200 1–24
SCI-A (n = 4)
    Median 194 53 1.8 29 2
    Range 130–467 29–82 0.2–7.1 10–200 1–14
SCI-NA (n = 3)
    Median 54 37 1.5 29 5
    Range 38–103 8–171 0.7–3.5 6–88 3–24
SCI+PU (n = 1)
    Median 33 54 8.6 6 27
    Range 27–70 49–55 6.7–9.3 6–8 24–30
CK = creatine kinase, CRP = C-reactive protein, H-FABP = heart-type fatty
acid binding protein, Mb = myoglobin, SCI = spinal cord injury, SCI-A = SCI
active, SCI-NA = SCI nonactive, SCI+PU = SCI plus pressure ulcer, U/L =
units per liter.368
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Figure 3.
Group results of marker concentrations of (a) creatine kinase (CK), (b) myoglobin (Mb), (c) heart-type fatty acid binding protein (H-
FABP), and (d) C-reactive protein (CRP) on 5 consecutive days. SCI group was presented both as single group and divided into two
groups according to motor function. SCI = spinal cord injury, SCI-A = SCI active, SCI-NA = SCI nonactive, SCI-PU = SCI plus pressure
ulcer, U/L = units per liter.369
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simultaneous increase in Mb, H-FABP, and CK, the former
two markers being of similar molecular size (15–18 kDa).
By contrast, the larger CK molecule (86 kDa) would lead
to a predicted delay in its increase compared with H-FABP
and Mb. Indeed, research examining myocardial infarction
and exercise revealed an increase in Mb and H-FABP at
similar time points and a delayed offset in CK [14,29–30].
In addition, in the SCI group, a significant negative corre-
lation was found between H-FABP and CRP and CK and
CRP (Table 3), corresponding to the results of Morse et al.
in which CRP levels of SCI subjects were negatively cor-
related with their activity levels [20].
Interestingly, previous research involving Mb and H-
FABP levels reported a larger increase in concentration
after myocardial infarction than the variations observed in
the present study [15,30]. For example, Glatz et al.
reported peak levels of Mb up to 20 times the baseline
range after myocardial infarction [30]. Additionally, con-
siderable increases of CK levels in serum and wound exu-
date were reported in animal studies on deep pressure
ulcers. Hagisawa et al. found a clear increase in CK con-
centration after 6 h mechanical loading (from ~500 U/L at
baseline to >1,500 U/L after loading) in a pig model [16].
In Sari et al., a clear increase in CK concentration was
observed (from ~30 U/L to ~200 U/L) [17]. Furthermore,
increased levels of CRP were present in SCI subjects with
pressure ulcers compared with subjects without ulcers
[12,19–20]. Since these elevations in marker levels were
much larger than the intra- and intersubject variations
observed in the present study within a period of 5 days,
this combination of four markers may prove appropriate
for the early detection of deep pressure ulcers.
In the present study, only one volunteer with a pres-
sure ulcer was recruited. This subject had a category II
ulcer, which is defined as partial thickness loss of the der-
mis [1]. This type of pressure ulcer is limited to the skin
layers, as opposed to deep pressure ulcers that involve
muscle tissue. Since three of the four markers that were
used in the present study reflect the presence of muscle
damage, it was unlikely that the category II ulcer in this
subject would cause increased levels of muscle damage
markers. Nevertheless, the same principle as proposed
for the early detection of deep pressure ulcers may also
hold for skin-confined ulcers. In this case, other markers
could be used that reflect the presence of skin damage,
such as the collagen degradation products hydroxylisine
and hydroxyproline [7].
The SCI subject with the pressure ulcer showed rela-
tively low CK concentrations compared with both the
SCI and control subjects, which can be attributed to a
decreased activity level. The CRP levels were increased
with respect to all individuals without ulcers, presumably
as a result of the inflammatory response associated with
the pressure ulcer. The H-FABP concentrations in this
subject were also high compared to the SCI group and the
nondisabled controls, whereas the Mb levels were com-
parable to the other subject groups. Therefore, the Mb/H-
FABP ratio was very low, although it was still within the
range reported by Pelsers et al. [23]. Most probably, the
large H-FABP concentrations of this subject are still
within the baseline variations. Indeed, it is unlikely that
this increase was a direct result of the pressure ulcer, as
the category II ulcer associated with this subject does not
involve muscle tissue. It would be interesting to investi-
gate the plasma concentrations of these four markers in
subjects with a category IV ulcer or deep tissue injury,
although the latter type of pressure ulcers is particularly
difficult to identify.
The selected muscle damage markers are separately
not unique indicators for skeletal muscle damage because
they are also present in cardiac tissue. The ratio Mb/H-
FABP has been reported to distinguish between damage
in these two muscle tissues [15]. In the present study,
however, comparison between SCI and control subjects
was unremarkable, with both cases yielding considerable
variations, as was evident in a study on nondisabled sub-
jects with a wide age range [23]. This large variation in
the Mb/H-FABP ratio is probably caused by the fact that
the baseline H-FABP concentration is relatively small.
The results of this study raise a number of topics to
be addressed if markers are to be used to assess early
changes in the integrity of skeletal muscles. For example,
Table 3.
Significant Spearman rank correlation coefficients between combinations
of markers for both control (lower left part of table) and SCI (upper right
part of table) group. NS indicates correlation coefficient was not
significant.
Control
SCI
CK Mb H-FABP CRP
CK NS 0.28 0.61
Mb 0.59 0.68 NS
H-FABP 0.60 0.74 0.29
CRP NS NS NS
CK = creatine kinase, CRP = C-reactive protein, H-FABP = heart-type fatty
acid binding protein, Mb = myoglobin, NS = not significant, SCI = spinal cord
injury.370
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the diurnal variations of Mb and H-FABP suggest the
importance of withdrawing blood at a fixed time point.
Indeed such a recommendation was made in a recent
study measuring the release of muscle damage and
inflammatory markers in response to eccentric exercise
in young, nondisabled subjects [31]. The time period
between sample testing is also important. Assuming that
the rise in markers is a rapid process and, in the worst
case scenario, the pressure ulcer develops very rapidly, it
might therefore be advisable to test marker levels every
day, particularly with high-risk subjects. For those more
susceptible to slowly developing pressure ulcers, a longer
time period between sample withdrawals may prove ade-
quate. Finally, as the intrasubject variations in marker
levels were smaller than the intersubject variations, it is
important to determine the baseline variations of an indi-
vidual to define a threshold above which an increase in
marker levels may indicate the development of a pressure
ulcer.
Only a small number of SCI subjects with a low-level
lesion participated in the present study. An extended study
might also include subjects with higher level lesions, who
generally present extended disuse atrophy leading to
decreased muscle volume. In such cases, more adipose tis-
sue is present and other more adipose or skin-related mark-
ers, such as hydroxylysine or hydroxyproline [32–33],
could be included in the blood analysis. In addition, further
studies might include female SCI subjects, in which case
the hormonal influence on muscle markers would need to
be accommodated [23,34].
CONCLUSIONS
In summary, the present study showed that each sub-
ject exhibited a unique concentration profile for all four
biomarkers that could, in part, be explained by their level
of physical activity. These intrasubject variations appeared
to be smaller than the intersubject variations. Furthermore,
a number of correlations between the different marker con-
centrations were found for both subject groups. No differ-
ences in baseline concentrations were found in CK, Mb,
and H-FABP between the SCI and control group. For CRP,
relatively high concentrations were observed in the SCI
group when compared with the nondisabled controls,
although the relatively small group numbers precluded any
confirmation by statistical analysis.
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